Epidemiology of triple negative breast cancers

Breast Disease

Volumn 32, Issue 1-2, 2010, Pages 5-24

  Gierach, Gierach L ^a   Burke, Aileen ^a   Anderson, William F ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Breast cancer; breast cancer epidemiology; breast cancer molecular subtypes; breast cancer risk factors; estrogen receptor (ER); human epidermal growth factor receptor 2 (HER2); progesterone receptor (PR); triple negative breast cancers

Indexed keywords

ALCOHOL; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

AGE; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; BREAST FEEDING; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER REGISTRY; CANCER RISK; CANCER SURVIVAL; EDUCATION; ETHNICITY; FAMILY HISTORY; GENE MUTATION; HORMONAL THERAPY; HUMAN; MENARCHE; MENOPAUSE; ONCOGENE; ORAL CONTRACEPTION; PARITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RACE DIFFERENCE; RISK FACTOR; TRIPLE NEGATIVE BREAST CANCER; UNITED STATES;

ADULT; AGED; BREAST NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RISK FACTORS; SEER PROGRAM; UNITED STATES; YOUNG ADULT;

EID: 80755169613     PISSN: 08886008     EISSN: 15581551     Source Type: Journal    
DOI: 10.3233/BD-2010-0319     Document Type: Article

References (73)

1. T. Sorlie, R. Tibshirani, J. Parker, T. Hastie, J. Marron, A. Nobel, S. Deng, H. Johnsen, R. Pesich, S. Geisler, J. Demeter, C. Perou, P. Lonning, P. Brown, A. Borresen-Dale and D. Botstein, Repeated observation of breast tumor subtypes in independent gene expression data sets, Proc Natl Acad Sci USA 100 (2003), 8418-8423. (Pubitemid 36842560)
2. N. Mavaddat, T.R. Rebbeck, S.R. Lakhani, D.F. Easton and A.C. Antoniou, Incorporating tumour pathology information into breast cancer risk prediction algorithms, Breast Cancer Res 12 (2010), R28.
3. W.F. Anderson, N. Chatterjee, W.B. Ershler and O.W. Brawley, Estrogen receptor breast cancer phenotypes in the Surveillance, Epidemiology, and End results database, Breast Cancer Res and Treat 76 (2002), 27-36. (Pubitemid 35178626)
4. M.-L. Asselin-Labat, F. Vaillant, J.M. Sheridan, B. Pal, D. Wu, E.R. Simpson, H. Yasuda, G.K. Smyth, T.J. Martin, G.J. Lindeman and J.E. Visvader, Control of mammary stem cell function by steroid hormone signalling, Nature 465 (2010), 798-802.
5. Surveillance Epidemiology and End Results (SEER) Program. (www.seer.cancer.gov) SEER*Stat Database: Incidence- SEER 13 Regs Research Data, Nov 2009 Sub (1992-2007) - Linked to County Attributes - Total U.S., 1969-2007 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2010, based on the November 2009 submission.
6. L.A. Carey and C.M. Perou, Gene arrays, prognosis, and therapeutic interventions, in: Diseases of the Breast, J.R. Harris et al., eds, Lippincott Williams and Wilkens: Philadelphia, 2009, p. 458-472.
7. C. Perou, T. Sorlie, M. Eisen, M. Rijn, S. Jeffrey, C. Rees, J. Pollack, D. Ross, H. Johnsen, L. Akslen, O. Fluge, A. Pergamenschikov, C. Williams, S. Zhu, P. Lonning, A. Borresen- Dale, P. Brown and D. Botstein, Molecular portraits of human breast tumours, Nature 406 (2000), 747-752.
8. T. Sorlie, C. Perou, R. Tibshirani, T. Aas, S. Geisler, H. Johnsen, T. Hastie, M. Eisen, M. Rijn, S. Jeffrey, T. Thorsen, H. Quist, J. Matese, P. Brown, D. Botstein, P. Eystein Lonning and A. Borresen-Dale, Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications, Proc Natl Acad Sci USA 98 (2001), 10869-10874. (Pubitemid 32878711)
9. A. Prat and C.M. Perou, Deconstructing the molecular portraits of breast cancer, Molecular Oncology 5 (2011), 5-23.
10. Z. Hu, C. Fan, D.S. Oh, J.S. Marron, X. He, B.F. Qaqish, C. Livasy, L.A. Carey, E. Reynolds, L. Dressler, A. Nobel, J. Parker, M.G. Ewend, L.R. Sawyer, J. Wu, Y. Liu, R. Nanda, M. Tretiakova, A. Ruiz Orrico, D. Dreher, J.P. Palazzo, L. Perreard, E. Nelson, M. Mone, H. Hansen, M. Mullins, J.F. Quackenbush, M.J. Ellis, O.I. Olopade, P.S. Bernard and C.M. Perou, The molecular portraits of breast tumors are conserved across microarray platforms, BMC Genomics 7 (2006), 96.
11. L. Perreard, C. Fan, J.F. Quackenbush, M. Mullins, N.P. Gauthier, E. Nelson, M. Mone, H. Hansen, S.S. Buys, K. Rasmussen, A.R. Orrico, D. Dreher, R. Walters, J. Parker, Z. Hu, X. He, J.P. Palazzo, O.I. Olopade, A. Szabo, C.M. Perou and P.S. Bernard, Classification and risk stratification of invasive breast carcinomas using a real-time quantitative RT-PCR assay, Breast Cancer Res 8 (2006), R23.
12. T. Sorlie, Y. Wang, C. Xiao, H. Johnsen, B. Naume, R.R. Samaha and A.L. Borresen-Dale, Distinct molecular mechanisms underlying clinically relevant subtypes of breast cancer: Gene expression analyses across three different platforms, BMC Genomics 7 (2006), 127.
13. C. Sotiriou, S.Y. Neo, L.M. McShane, E.L. Korn, P.M. Long, A. Jazaeri, P. Martiat, S.B. Fox, A.L. Harris and E.T. Liu, Breast cancer classification and prognosis based on gene expression profiles from a population-based study, Proc Natl Acad Sci USA 100 (2003), 10393-10398. (Pubitemid 37071889)
14. C.A. Livasy, G. Karaca, R. Nanda, M.S. Tretiakova, O.I. Olopade, D.T. Moore and C.M. Perou, Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma, Modern Pathology 19 (2006), 264-271. (Pubitemid 43117611)
15. C.A. Livasy, C.M. Perou, G. Karaca, D.W. Cowan, D.Maia, S. Jackson, C.K. Tse, S. Nyante and R.C.Millikan, Identification of a basal-like subtype of breast ductal carcinoma in situ, Human Pathology 38 (2007), 197-204. (Pubitemid 46096566)
16. R.M. Tamimi, H.J. Baer, J. Marotti, M. Galan, L. Galaburda, Y. Fu, A.C.Deitz, J.L.Connolly, S.J. Schnitt, G.A. Colditz and L.C. Collins, Comparison of molecular phenotypes of ductal carcinoma in situ and invasive breast cancer, Breast Cancer Res 10 (2008), R67.
17. K. Yu, C.H. Lee, P.H. Tan and P. Tan, Conservation of breast cancer molecular subtypes and transcriptional patterns of tumor progression across distinct ethnic populations, Clinical Cancer Res 10 (2004), 5508-5517. (Pubitemid 39100489)
18. S. Calza, P. Hall, G. Auer, J. Bjohle, S. Klaar, U. Kronenwett, E.T. Liu, L. Miller, A. Ploner, J. Smeds, J. Bergh and Y. Pawitan, Intrinsic molecular signature of breast cancer in a population-based cohort of 412 patients, Breast Cancer Res 8 (2006), R34.
19. C.U. Ihemelandu, L.D. Leffall, Jr., R.L. Dewitty, T.J. Naab, H.M. Mezghebe, K.H. Makambi, L. Adams-Campbell and W.A. Frederick, Molecular breast cancer subtypes in premenopausal and postmenopausal African-American women: age-specific prevalence and survival, J Surg Res 143 (2007), 109-118. (Pubitemid 47562451)
20. T.O. Nielsen, F.D. Hsu, K. Jensen, M. Cheang, G. Karaca, Z. Hu, T.Hernandez-Boussard, C. Livasy, D. Cowan, L.Dressler, L.A. Akslen, J. Ragaz, A.M. Gown, C.B. Gilks, M. van de Rijn and C.M. Perou, Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma, Clin Cancer Res 10 (2004), 5367-5374. (Pubitemid 39100473)
21. D.M. Abd El-Rehim, G. Ball, S.E. Pinder, E. Rakha, C. Paish, J.F. Robertson, D. Macmillan, R.W. Blamey and I.O. Ellis, High-throughput protein expression analysis using tissue microarray technology of a large well-characterized series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analysis, Int J Cancer 116 (2005), 340-350. (Pubitemid 40993329)
22. L. Carey, C. Perou, C. Livasy, L. Dressler, D. Cowan, K. Conway, G. Karaca, M. Troester, C. Tse, S. Edmiston, S. Deming, J. Geradts, M. Cheang, T. Nielsen, P. Moorman, H. Earp and R. Millikan, Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study, JAMA 295 (2006), 2492-2502. (Pubitemid 43854964)
23. W.F. Anderson, S. Luo, N. Chatterjee, P.S. Rosenberg, R.K. Matsuno, M.T. Goodman, B.Y. Hernandez, M. Reichman, M.P. Dolled-Filhart, R.M. O'Regan, M. Garcia-Closas, C.M. Perou, I. Jatoi, R.W. Cartun andM.E. Sherman,Human epidermal growth factor receptor-2 and estrogen receptor expression, a demonstration project using the residual tissue respository of the Surveillance, Epidemiology, and End Results (SEER) program, Breast Cancer Res Trea 113 (2009), 189-196.
24. C. Fan, D. Oh, L. Wessels, B. Weigelt, D. Nuyten, A. Nobel, L. van't Veer and C. Perou, Concordance among geneexpression- based predictors for breast cancer, N Engl J Med 355 (2006), 560-569. (Pubitemid 44200649)
25. I. Jatoi, W.F. Anderson, J.H. Jeong and C.K. Redmond, Breast cancer adjuvant therapy: time to consider its time-dependent effects, J Clin Oncol 29 (2011), 2301-2304.
26. E.P. Winer, L.A. Carey, M. Dowsett and D. Tripathy, Beyond anatomic staging: are we ready to take the leap to molecular classification? in: American Society of Clinical Onocolgy Education Book,M.C. Perry, ed.,American Society ofClinical Oncology: Alexandria, VA, 2005, pp. 46-59.
27. W.F. Symmans, A pathologist's perspective on emerging genomic tests for breast cancer, Seminars in Oncology 34 (2007), S4-9. (Pubitemid 46754434)
28. L. Pusztai, C. Mazouni, K. Anderson, Y. Wu and W.F. Symmans, Molecular classification of breast cancer: limitations and potential, The Oncologist 11 (2006), 868-877. (Pubitemid 44373759)
29. T. Sorlie, Introducing molecular subtyping of breast cancer into the clinic? J Clin Oncol 27 (2009), 1153-1154.
30. J.S. Reis-Filho and S.R. Lakhani, Breast cancer special types: why bother? Journal of Pathology 216 (2008), 394-398.
31. M.E. Reichman, S. Altekruse, C.I. Li, V.W. Chen, D. Deapen, M. Potts, X.-C.Wu, D.Morrell, J. Hafterson, A.I. Phipps, L.C. Harlan, L.G. Ries and B.K. Edwards, Feasibility Study for Collection of HER2 Data by National Cancer Institute (NCI) Surveillance, Epidemiology, and End Results (SEER) Program Central Cancer Registries, Cancer Epidemiol Biomarkers Prev 19 (2010), 144-147.
32. J. Clemmesen, Carcinoma of the breast, British Journal of Radiology 21 (1948), 583-590.
33. D.B. Thomas, Breast cancer in men, Epidemiologic Reviews 15 (1993), 220-231. (Pubitemid 23269085)
34. W.F. Anderson, I. Jatoi and M.E. Sherman, Qualitative age interactions in breast cancer studies: mind the gap, J Clin Oncol 27 (2009), 5308-5311.
35. W.F. Anderson and R.Matsuno, Breast Cancer Heterogeneity: A Mixture of At Least Two Main Types? J Natl Cancer Inst 98 (2006), 948-951. (Pubitemid 44288160)
36. R.B. Clarke, A.H. Sims and A. Howell, The origin of estrogen receptor alpha-positive and alpha-negative breast cancer, Advances in Experimental Medicine and Biology 617 (2008), 79-86.
37. Y. Yasui and J.D. Potter, The shape of age - incidence curves of female breast cancer by hormone-receptor status, Cancer Causes and Control 10 (1999), 431-437. (Pubitemid 29454321)
38. A. Kurian, K. Fish, S. Shema and C. Clarke, Lifetime risks of specific breast cancer subtypes among women in four racial/ethnic groups, Breast Cancer Res 12 (2010), R99.
39. K.C. Amirikia, P. Mills, J. Bush and L.A. Newman, Higher population-based incidence rates of triple-negative breast cancer among young African-American women, Cancer 117 (2011), 2747-2753.
40. C.A. Parise, K.R. Bauer and V. Caggiano, Variation in breast cancer subtypes with age and race/ethnicity, Critical Reviews in Oncology/Hematology 76 (2010), 44-52.
41. D. Huo, F. Ikpatt, A. Khramtsov, J. Dangou, R. Nanda, J. Dignam, B. Zhang, T. Grushko, C. Zhang, O. Oluwasola, D. Malaka, S. Malami, A. Odetunde, A. Adeoye, F. Iyare, A. Falusi, C. Perou and O. Olopade, Population differences in breast cancer: survey in indigenous African women reveals over-representation of triple-negative breast cancer, J Clin Oncol 27 (2009), 4515-4521.
42. W. Anderson, P. Rosenberg, I. Menashe, A. Mitani and R. Pfeiffer, Age-related crossover in breast cancer incidence rates between black and white ethnic groups, J Natl Cancer Inst 100 (2008), 1804-1814.
43. E.L. Kaplan and P. Meier, Nonparametric estimation from incomplete observations, Journal of American Statistical Association 53 (1958), 457-481.
44. P.S. Rosenberg, Hazard function estimation using B-splines, Biometrics 51 (1995), 874-887.
45. W.F. Anderson, C. Schairer, B.E. Chen, K.C. Hance and P.H. Levine, Epidemiology of inflammatory breast cancer (IBC), Breast Dis 22 (2005-2006), 9-23. (Pubitemid 44308938)
46. W.F. Anderson, B.E. Chen, I. Jatoi and P.S. Rosenberg, Effects of estrogen receptor expression and histopathology on annual hazard rates of death from breast cancer, Breast Cancer Res Treat 100 (2006), 121-126.
47. I. Jatoi, B.E. Chen,W.F. Anderson and P.S. Rosenberg, Breast cancer mortality trends in the United States according to estrogen receptor status and age at diagnosis, J Clin Oncol 25 (2007), 1683-1690. (Pubitemid 46797948)
48. I. Menashe, W.F. Anderson, I. Jatoi and P.S. Rosenberg, Underlying causes of the Black-White racial disparity in breast cancer mortality: a population-based analysis, JNCI 101 (2009), 993-1000.
49. J.M. Dolle, J.R. Daling, E. White, L.A. Brinton, D.R. Doody, P.L. Porter and K.E.Malone, Risk Factors for Triple-Negative Breast Cancer in Women Under the Age of 45 Years, Cancer Epidemiol Biomarkers Prev (2009), 1055-9965.EPI-1008-1005.
50. H. Ma, Y. Wang, J. Sullivan-Halley, L. Weiss, P.A. Marchbanks, R. Spirtas, G. Ursin, R.T. Burkman, M.S. Simon, K.E. Malone, B.L. Strom, J.A.McDonald, M.F. Press and L. Bernstein, Use of four biomarkers to evaluate the risk of breast cancer subtypes in the women's contraceptive and reproductive experiences study, Cancer Res 70 (2010), 575-587.
51. R. Millikan, B. Newman, C. Tse, P. Moorman, K. Conway, L. Dressler, L. Smith, M. Labbok, J. Geradts, J. Bensen, S. Jackson, S. Nyante, C. Livasy, L. Carey, H. Earp and C. Perou, Epidemiology of basal-like breast cancer, Breast Cancer Res Treat 109 (2008), 123-139. (Pubitemid 351538762)
52. A. Phipps, K. Malone, P. Porter, J. Daling and C. Li, Reproductive and hormonal risk factors for postmenopausal lumi nal, HER-2-overexpressing, and triple-negative breast cancer, Cancer 113 (2008), 1521-1526.
53. A. Phipps, K.Malone, P. Porter, J. Daling and C. Li, Body size and risk of luminal, HER2-overexpressing, and triple-negative breast cancer in postmenopausal women, Cancer Epidemiol Biomarkers Prev 17 (2008), 2078-2086.
54. K.F. Trivers, M.J. Lund, P.L. Porter, J.M. Liff, E.W. Flagg, R.J. Coates and J.W. Eley, The epidemiology of triple-negative breast cancer, including race, Cancer Causes Control 20 (2009), 1071-1082.
55. X. Yang, M. Sherman, D. Rimm, J. Lissowska, L. Brinton, B. Peplonska, S. Hewitt,W.Anderson, N. Szeszenia-Dabrowska, A. Bardin-Mikolajczak, W. Zatonski, R. Cartun, D. Mandich, G. Rymkiewicz, M. Ligaj, S. Lukaszek, R. Kordek and M. Garcia-Closas, Differences in risk factors for breast cancer molecular subtypes in a population-based study, Cancer Epidemiol Biomarkers Prev 16 (2007), 439-443. (Pubitemid 46548646)
56. P. Xing, J. Li and F. Jin, A case-control study of reproductive factors associated with subtypes of breast cancer in Northeast China, Med Oncol 27 (2010), 926-931.
57. C. Begg and Z. Zhang, Statistical analysis of molecular epidemiology studies employing case-series, Cancer Epidemiol Biomarkers Prev 3 (1994), 173-175.
58. M.E. Martinez, G.I. Cruz, A.M. Brewster, M.L. Bondy and P.A. Thompson, What can we learn about disease etiology from case-case analyses? Lessons from breast cancer, Cancer Epidemiol Biomarkers Prev 19 (2010), 2710-2714.
59. M.L. Kwan, L.H. Kushi, E. Weltzien, B. Maring, S.E. Kutner, R.S. Fulton, M.M. Lee, C.B. Ambrosone and B.J. Caan, Epidemiology of breast cancer subtypes in two prospective cohort studies of breast cancer survivors, Breast Cancer Res 11 (2009), R31.
60. C. Parise, K. Bauer, M. Brown and V. Caggiano, Breast cancer subtypes as defined by the estrogen receptor (ER), progesterone receptor (PR), and the human epidermal growth factor receptor 2 (HER2) among women with invasive breast cancer in California, 1999-2004, Breast J 15 (2009), 593-602.
61. A. Stark, A. Kapke, D. Schultz, R. Brown, M. Linden andU. Raju, Advanced stages and poorly differentiated grade are associated with an increased risk of HER2/neu positive breast carcinoma only in White women: findings from a prospective cohort study of African-American and White-American women, Breast Cancer Res Treat 107 (2008), 405-414. (Pubitemid 351172112)
62. A. Stark, D. Schultz, A. Kapke, P. Nadkarni, M. Burke, M. Linden and U. Raju, Obesity and risk of the less commonly diagnosed subtypes of breast cancer, Eur J Surg Oncol 35 (2009), 928-935.
63. L. Stead, T. Lash, J. Sobieraj, D. Chi, J. Westrup, M. Charlot, R. Blanchard, J. Lee, T. King and C. Rosenberg, Triplenegative breast cancers are increased in black women regardless of age or body mass index, Breast Cancer Res 11 (2009), R18.
64. S.S. Shinde,M.R. Forman, H.M.Kuerer, K.Yan, F. Peintinger, K.K. Hunt, G.N. Hortobagyi, L. Pusztai and W.F. Symmans, Higher parity and shorter breastfeeding duration: Association with triple-negative phenotype of breast cancer, Cancer 116 (2010), 4933-4943.
65. X.R. Yang, J. Chang-Claude, E.L. Goode, F.J. Couch, H. Nevanlinna, R.L.Milne, M. Gaudet,M.K. Schmidt, A. Broeks, A. Cox, P.A. Fasching, R. Hein, A.B. Spurdle, F. Blows, K. Driver, D. Flesch-Janys, J. Heinz, P. Sinn, A. Vrieling, T. Heikkinen, K. Aittomäki, P. Heikkilä, C. Blomqvist, J. Lissowska, B. Peplonska, S. Chanock, J. Figueroa, L. Brinton, P. Hall, K. Czene, K. Humphreys, H. Darabi, J. Liu, L.J. Van't Veer, F.E. van Leeuwen, I.L. Andrulis, G. Glendon, J.A. Knight, A.M. Mulligan, F.P. O'Malley, N. Weerasooriya, E.M. John, M.W. Beckmann, A. Hartmann, S.B. Weihbrecht, D.L. Wachter, S.M. Jud, C.R. Loehberg, L. Baglietto, D.R. English, G.G. Giles, C.A.McLean, G. Severi, D. Lambrechts, T. Vandorpe, C. Weltens, R. Paridaens, A. Smeets, P. Neven, H. Wildiers, X. Wang, J.E. Olson, V. Cafourek, Z. Fredericksen, M. Kosel, C. Vachon, H.E. Cramp, D. Connley, S.S. Cross, S.P. Balasubramanian, M.W.R. Reed, T. Dörk, M. Bremer, A. Meyer, J.H. Karstens, A. Ay, T.-W. Park-Simon, P. Hillemanns, J.I. Arias Pérez, P.M. Rodr̈iguez, P. Zamora, J. Beńitez, Y.-D. Ko, H.-P. Fischer, U. Hamann, B. Pesch, T. Br̈uning, C. Justenhoven, H. Brauch, D.M. Eccles, W.J. Tapper, S.M. Gerty, E.J. Sawyer, I.P. Tomlinson, A. Jones, M. Kerin, N. Miller, N. McInerney, H. Anton-Culver, A. Ziogas,C.-Y. Shen, C.-N. Hsiung, P.-E. Wu, S.-L. Yang, J.-C. Yu, S.-T. Chen, G.-C. Hsu, C.A. Haiman, B.E. Henderson, L. Le Marchand, L.N. Kolonel, A. Lindblom, S. Margolin, A. Jakubowska, J. Lubínski, T. Huzarski, T. Byrski, B. Górski, J. Gronwald, M.J. Hooning, A. Hollestelle, A.M.W. van den Ouweland, A. Jager, M. Kriege, M.M.A. Tilanus-Linthorst, M. Collée, S.Wang-Gohrke, K. Pylkäs, A. Jukkola-Vuorinen, K. Mononen, M. Grip, P. Hirvikoski, R. Winqvist, A. Mannermaa, V.-M. Kosma, J. Kauppinen, V. Kataja, P. Auvinen, Y. Soini, R. Sironen, S.E. Bojesen, D. Dynnes Orsted, D. Kaur-Knudsen, H. Flyger, B.G. Nordestgaard, H. Holland, G. Chenevix-Trench, S. Manoukian, M. Barile, P. Radice, S.E. Hankinson, D.J. Hunter, R. Tamimi, S. Sangrajrang, P. Brennan, J. McKay, F. Odefrey, V. Gaborieau, P. Devilee, P.E.A. Huijts, R. Tollenaar, C. Seynaeve, G.S. Dite, C. Apicella, J.L. Hopper, F. Hammet, H. Tsimiklis, L.D. Smith, M.C. Southey, M.K. Humphreys, D. Easton, P. Pharoah, M.E. Sherman and M. Garcia-Closas, Associations of Breast Cancer Risk Factors With Tumor Subtypes: A Pooled Analysis From the Breast Cancer Association Consortium Studies, J Nat Cancer Inst 103 (2011), 250-263.
66. G. Kabat, M. Kim, A. Phipps, C. Li, C. Messina, J.Wactawski- Wende, L. Kuller, M. Simon, S. Yasmeen, S. Wassertheil- Smoller and T. Rohan, Smoking and alcohol consumption in relation to risk of triple-negative breast cancer in a cohort of postmenopausal women, Cancer Causes and Control (2011), 1-9.
67. A. Phipps, D. Buist, K. Malone, W. Barlow, P. Porter, K. Kerlikowske and C. Li, Reproductive history and risk of three breast cancer subtypes defined by three biomarkers, Cancer Causes and Control 22 (2011), 399-405.
68. A.I. Phipps, R.T. Chlebowski, R. Prentice, A. McTiernan, M.L. Stefanick, J. Wactawski-Wende, L.H. Kuller, L.L. Adams-Campbell, D. Lane, M. Vitolins, G.C. Kabat, T.E. Rohan and C.I. Li, Body Size, Physical Activity, and Risk of Triple-Negative and Estrogen Receptor-Positive Breast Cancer, Cancer Epidemiol Biomarkers Prev 20 (2011), 454-463.
69. A.I. Phipps, R.T. Chlebowski, R. Prentice, A. McTiernan, J. Wactawski-Wende, L.H. Kuller, L.L. Adams-Campbell, D. Lane, M.L. Stefanick, M. Vitolins, G.C. Kabat, T.E. Rohan and C.I. Li, Reproductive History and Oral Contraceptive Use in Relation to Risk of Triple-Negative Breast Cancer, J Nat Cancer Inst 103 (2011), 470-477.
70. A. Phipps, D. Buist, K. Malone, W. Barlow, P. Porter, K. Kerlikowske and C. Li, Family history of breast cancer in firstdegree relatives and triple-negative breast cancer risk, Breast Cancer Res Treat 126 (2011), 671-678.
71. M.D. Althuis, J.H. Fergenbaum, M. Garcia-Closas, L.A. Brinton, M.P. Madigan and M.E. Sherman, Etiology of hormone receptor-defined breast cancer: a systematic review of the literature, Cancer Epidemiol Biomarkers Prev 13 (2004), 1558-1568. (Pubitemid 39331875)
72. H. Akaike, Information Theory and an extension of the maximum likelihood principle, in: 2nd International Symposium on Information Theory, Budapest: Akademiai Kiado, 1973, 267-281.
73. B. Efron, The Jackknife, the bootstrap, and other resampling plans Society for Industrial and Applied Mathematics, Philadelphia, 1982.